Answers are grounded in this paper and cite their sources.
Background: The mechanisms underlying the pathogenesis of aortic aneurysms and aortic dissections remain not fully clear. However, inflammation has been considered as a central player in the development of these conditions. On the other hand, different inflammatory histological patterns may exist in the context of these pathologies. Objectives: To perform a comparative study of the different inflammatory patterns observed in patients undergoing surgery for aortic aneurysm or aortic dissection. Methods: We reviewed aortic biopsies from patients who had undergone cardiovascular surgery from February 2022 to December 2023 from a referral centre. Biopsies were analysed by an expert pathologist. The inflammatory pattern was defined by the presence of inflammation in any of the aortic layers. Based on the inflammatory findings, aortic biopsies were classified into 4 categories: a) vasa vasorum inflammation, b) periaortic fibrosis, c) vasa vasorum inflammation with periaortic fibrosis and d) inflammation of the intimal, medial o adventitial layer without others histological findings. Results: We present 44 patients (11 female/33 male) with a mean age of 65.2±10.1 years who underwent surgery for aortic aneurysm or aortic dissection, in whom inflammatory histological findings were observed. The main features of the patients are summarized in Figure 1. The histological samples corresponded to: thoracic aortic aneurysm (n=38; 86.4%), abdominal aortic aneurysm (n=2; 9.1%), and aortic dissection without previous aneurysm (n=4; 4.5%). The inflammatory patterns observed were: vasa vasorum involvement (n=8; 14%); periaortic fibrosis (n=6; 10.5%); vasa vasorum involvement and periaortic fibrosis (n=13; 22.8%); and no involvement of the above (n=30; 52.6%). Patients with vasa vasorum involvement were more likely to smoke than those with other patterns. (41.2 vs. 100%; p= 0077). The only patient with GCA had both vasa vasorum involvement and periaortic fibrosis. Conclusion: In the present study, we found no significant differences in the features of patients with different inflammatory histological patterns. REFERENCES: NIL. Acknowledgements: NIL. Disclosure of Interests: Adrián Martín-Gutiérrez: None declared, Javier Loricera Roche, Galápagos, Novartis, UCB Pharma, MSD, Celgene, Astra Zeneca, and Grünenthal, Janssen, Abbvie, Roche, Novartis, MSD, UCB Pharma, Celgene, Lilly, Pfizer, Galápagos, Jose María Gómez-Ortega: None declared, Ander Ucelay: None declared, Carmen Secada-Gómez: None declared, Fernando López-Gutiérrez Janssen, Abbvie, Roche, Novartis, MSD, UCB Pharma, Celgene, Lilly, Pfizer, Galápagos, Ricardo Blanco AbbVie, Pfizer, Roche, GSK, Lilly, UCB, Bristol-Myers, Novartis, Janssen, UCB and MSD, AbbVie, MSD, and Roche.
No takes yet. Share an insight, caveat, or question.
Martín-Gutiérrez et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: